Literature DB >> 32149390

Clinical trials-Designing, implementing, and collaborating.

Christina L Roland1, Elizabeth G Grubbs1, Matthew H G Katz1, Mediget Teshome2, Kelly K Hunt1,2, Ching-Wei Tzeng1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32149390      PMCID： PMC7598771          DOI： 10.1002/jso.25889

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  7 in total

1.  Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century.

Authors:  M Leavitt
Journal:  MedGenMed       Date:  2001-03-05

2.  Clinical research in surgical oncology: an analysis of ClinicalTrials.gov.

Authors:  Amber S Menezes; Alison Barnes; Adena S Scheer; Guillaume Martel; Husein Moloo; Robin P Boushey; Elham Sabri; Rebecca C Auer
Journal:  Ann Surg Oncol       Date:  2013-06-26       Impact factor: 5.344

3.  Research waste in surgical randomized controlled trials.

Authors:  S J Chapman; M Aldaffaa; C L Downey; D G Jayne
Journal:  Br J Surg       Date:  2019-08-08       Impact factor: 6.939

4.  Comparison of Population-Based Observational Studies With Randomized Trials in Oncology.

Authors:  Payal D Soni; Holly E Hartman; Robert T Dess; Ahmed Abugharib; Steven G Allen; Felix Y Feng; Anthony L Zietman; Reshma Jagsi; Matthew J Schipper; Daniel E Spratt
Journal:  J Clin Oncol       Date:  2019-03-21       Impact factor: 44.544

5.  In and out, good and bad news, of generalizability of SWOG treatment trial results.

Authors:  Archie Bleyer
Journal:  J Natl Cancer Inst       Date:  2014-03-13       Impact factor: 13.506

6.  Comparison of survival outcomes among cancer patients treated in and out of clinical trials.

Authors:  Joseph M Unger; William E Barlow; Diane P Martin; Scott D Ramsey; Michael Leblanc; Ruth Etzioni; Dawn L Hershman
Journal:  J Natl Cancer Inst       Date:  2014-03-13       Impact factor: 13.506

Review 7.  Novel cancer immunotherapy agents with survival benefit: recent successes and next steps.

Authors:  Padmanee Sharma; Klaus Wagner; Jedd D Wolchok; James P Allison
Journal:  Nat Rev Cancer       Date:  2011-10-24       Impact factor: 60.716
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.